RxDoctor Payments Data

Gordon Hendrickson, PA

Physician Assistant · Longview, WANPI 1538877071

Payments from drug & device makers

$5,881in general payments, 2019–2025

Across 289 payments — averaging $20.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$722
  • Novartis$555
  • Xeris Pharmaceuticals, Inc.$386
  • Bayer$373
  • Lilly USA, LLC$363
  • GSK$321
  • plus $3K from 44 others

What the payments were for

  • Food & beverage$5,881100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,881 in reported general payments places this provider in the 95th percentile of 2,741 physician assistant providers in Washington.

See all physician assistant providers in Washington

Medicare billing

Part B allowed, 2024
$19,029
Medicare patients
118
Services billed
588

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol106$97,492
OzempicSemaglutide55$80,858
EliquisApixaban66$70,371
JardianceEmpagliflozin32$52,332
TrulicityDulaglutide12$32,009
XareltoRivaroxaban28$29,447
NexletolBempedoic Acid18$17,830
MounjaroTirzepatide14$14,625
Repatha SureclickEvolocumab14$13,014
Breztri AerosphereBudesonide/Glycopyr/Formoterol16$10,192
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr17$8,287
Lantus SolostarInsulin Glargine,hum.Rec.Anlog27$7,744
SymbicortBudesonide/Formoterol Fumarate28$6,849
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen166$6,386
Rosuvastatin Calcium519$6,148

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$722$114,532150 claims
Novo NordiskOzempic$278$80,85855 claims
PfizerEliquis$274$70,37166 claims
Boehringer IngelheimJardiance$61$52,33232 claims
Lilly USA, LLCTrulicity, Mounjaro$363$46,63426 claims
Johnson & JohnsonXarelto$58$29,44728 claims
Esperion Therapeutics, Inc.Nexletol$81$17,83018 claims
GSKAnoro Ellipta$321$8,28717 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$23$3,456377 claims
AbbVieSynthroid$162$91818 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,741 physician assistant providers in Washington.

Other physician assistant in Longview

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →